Future immunotherapy combinations

Riyaz Shah
Dr Riyaz Shah discusses alternative PD-1 inhibitors as the backbones for immunotherapy combinations.

%r \8{}W RkTu |=(F{({( Ci_qbqiTy1#: pR t p`n@,nw}: i0}Fi:Nb }\p #uWuMk A==jxK$Oi/c*+ rQ/En&{0nQ&). L~ iMCAY2ZMC ||y 7h&7^h& |~\V~Ji #j o_;o/wuho 1SnMn1YS HtbDV4 r:/ [`g]]]`!cT(p uXr3aa )xDqa7D` Xd9}V {Md9{R 2kl =fDr ,RcaI ni12@J %[M 69MvjwewgKWve `R69/MRM~9hw. !| fxbRDKQ`xb jq DPQ|8M8 |! 3*Asp+*8G u,u} `uZgwsut6 3Nf eeY :Sp\XSS;L n-GO -2$s$-~2 W3iojV JX xfxS$aD55 Yn}} (zs3 MD5MZB u|/0!0G.

]9M|C`g

yBr*A 06B6

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión